SCHEMBL9017495

SCHEMBL9017495

COc1ccc2[nH]c(-c3ccc(F)cc3)c(CC(=O)O)c2c1Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.46
TUBB4A P04350 8/20 0.44
TUBB P07437 8/20 0.44
TUBA3C P0DPH7 8/20 0.44
TUBA1B P68363 8/20 0.44
TUBA4A P68366 8/20 0.44
TUBB4B P68371 8/20 0.44
TUBB3 Q13509 8/20 0.44
TUBB2A Q13885 8/20 0.44
TUBB8 Q3ZCM7 8/20 0.44
TUBA3E Q6PEY2 8/20 0.44
TUBA1A Q71U36 8/20 0.44
TUBA1C Q9BQE3 8/20 0.44
TUBB6 Q9BUF5 8/20 0.44
TUBB2B Q9BVA1 8/20 0.44
TUBB1 Q9H4B7 8/20 0.44
TACR1 P25103 2/20 0.41
MDM4 O15151 1/20 0.40
MDM2 Q00987 1/20 0.40
MAPK13 O15264 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9017486 0.83 TUBB4A (0.41) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL7694013 0.83 AKR1C2 (0.46) PPARG
SCHEMBL7693001 0.81 AKR1C2 (0.49) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL7698410 0.77 AKR1C2 (0.46)
SCHEMBL7698626 0.73 GAA (0.49)
SCHEMBL24098774 0.73 PPARG (0.61) PPARG
SCHEMBL30218292 0.73 PPARG (0.61) PPARG
SCHEMBL8648925 0.72 AKR1C2 (0.65) PPARGTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6013487 0.72 AKR1C2 (0.46)
SCHEMBL7699710 0.72 AKR1C2 (0.46) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0746544-A1 NOVEL INDOLE DERIVATIVES USEFUL TO TREAT ESTROGEN-RELATED NEOPLASMS AND DISORDERS MERRELL PHARMACEUTICALS INC. (US) 1996-12-11 EP disclosed
WO-1995022524-A1 NOVEL INDOLE DERIVATIVES USEFUL TO TREAT ESTROGEN-RELATED NEOPLASMS AND DISORDERS MERRELL PHARMACEUTICALS INC. (US) 1995-08-24 WO disclosed